Carrie L. Bourdow
President, CEO & ChairmanMs. Carrie L. Bourdow has been Chief Executive Officer, President and Director at Trevena, Inc. since October 01, 2018 and serves as its Chairman since November 09, 2023. Ms. Bourdow served as an Executive Vice President and Chief Operating Officer of Trevena, Inc. from January 2018 to October 01, 2018. Ms. Bourdow was the Chief Commercial Officer and Senior Vice President of Trevena, Inc. since May 2015 until January 2018. Ms. Bourdow has experience in pharmaceutical sales and marketing. From May 2013 to May 2015. Ms. Bourdow was Vice President of Marketing, Reimbursement and Operations at Cubist Pharmaceuticals, Inc. Ms. Bourdow was vice president of marketing at Cubist Pharmaceuticals, Inc. from 2013 until its acquisition by Merck & Co. Incorporated in January 2015. At Cubist, Ms. Bourdow led launch strategy, marketing, reimbursement and operations for acute care hospital pharmaceuticals. Prior to joining Cubist in 2013, Ms. Bourdow served at Merck & Co. Inc. where she held positions of increasing responsibility across several therapeutic areas including anti-infectives, acute heart failure and pain. She had been Director of Nabriva Therapeutics plc since June 23, 2017 until July 2023 and as Director of Nabriva Therapeutics GmbH. She had been Independent Director of Sesen Bio, Inc since February 20, 2020 until March 2023. Ms. Bourdow has a Bachelor of Arts degree from Hendrix College and earned her Master’s in Business Administration from Southern Illinois University.
Positions
- Company NameTrevena, Inc.Stock CodeTRVNPositionPresident, CEO & ChairmanColleagues
- MAMark A. DemitrackSenior VP & Chief Medical Officer
- HAHoward A. RockmanScientific Founder, Consultant and Member of Scientific Advisory Board
- KSKatrine SuttonPrincipal Financial Officer & principal accounting officer
- RTRobert T. YoderSenior VP, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
- BYBarbara YanniIndependent Director
- RJRobert J. LefkowitzMember of Scientific Advisory Board
- JLJohn L. LaMattinaMember of the Scientific Advisory Board
